drugset / Trial / NCT06221826
MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
The use of metabolic modulators creates prospects for increasing the efficiency of the rehabilitation treatment of patients with acute cerebral failure
Timeline
- Start
- 2023-04-17
- Primary completion
- 2023-09-12
- Completion
- 2023-09-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EMOXYPINE | Small molecule | 250 mg | Intravenous |